Gilead Sciences Common
(GILD)
|
4.0 |
$117M |
|
1.8M |
64.63 |
Amgen Common
(AMGN)
|
3.6 |
$104M |
|
417k |
248.81 |
Johnson & Johnson Common
(JNJ)
|
3.4 |
$99M |
|
605k |
164.35 |
Illumina Common
(ILMN)
|
3.3 |
$95M |
|
247k |
384.06 |
Abbott Laboratories Common
(ABT)
|
3.1 |
$89M |
|
744k |
119.84 |
Vertex Pharmaceuticals Common
(VRTX)
|
2.9 |
$85M |
|
395k |
214.89 |
Unitedhealth Group Common
(UNH)
|
2.7 |
$79M |
|
212k |
372.07 |
Horizon Therapeutics Shares
|
2.6 |
$75M |
|
811k |
92.04 |
Regeneron Pharmaceuticals Common
(REGN)
|
2.5 |
$73M |
|
154k |
473.14 |
Biogen Common
(BIIB)
|
2.4 |
$69M |
|
247k |
279.75 |
AbbVie Common
(ABBV)
|
2.3 |
$67M |
|
620k |
108.22 |
Moderna Common
(MRNA)
|
2.1 |
$62M |
|
472k |
130.95 |
Anthem Common
(ELV)
|
2.0 |
$59M |
|
165k |
358.95 |
Medtronic Shares
(MDT)
|
2.0 |
$58M |
|
492k |
118.13 |
Bristol-Myers Squibb Common
(BMY)
|
1.9 |
$56M |
|
893k |
63.13 |
Eli Lilly and Common
(LLY)
|
1.9 |
$55M |
|
292k |
186.82 |
Thermo Fisher Scientific Common
(TMO)
|
1.8 |
$52M |
|
114k |
456.38 |
Cigna Corp. Common
(CI)
|
1.6 |
$46M |
|
190k |
241.74 |
Danaher Corp. Common
(DHR)
|
1.5 |
$43M |
|
191k |
225.08 |
Merck & Co Common
(MRK)
|
1.4 |
$42M |
|
542k |
77.09 |
Stryker Corp. Common
(SYK)
|
1.3 |
$37M |
|
152k |
243.58 |
Zimmer Biomet Holdings Common
(ZBH)
|
1.1 |
$33M |
|
208k |
160.08 |
Seagen Common
|
1.1 |
$31M |
|
226k |
138.86 |
Waters Corp. Common
(WAT)
|
1.0 |
$29M |
|
103k |
284.17 |
HCA Healthcare Common
(HCA)
|
1.0 |
$29M |
|
153k |
188.34 |
Dexcom Common
(DXCM)
|
0.9 |
$27M |
|
75k |
359.39 |
ResMed Common
(RMD)
|
0.9 |
$26M |
|
132k |
194.02 |
Pfizer Common
(PFE)
|
0.9 |
$26M |
|
705k |
36.23 |
Laboratory Corp. of America Holdings Sponsored ADR
|
0.9 |
$25M |
|
100k |
255.03 |
Exelixis Common
(EXEL)
|
0.9 |
$25M |
|
1.1M |
22.59 |
McKesson Corp. Common
(MCK)
|
0.8 |
$25M |
|
126k |
195.04 |
Guardant Health Common
(GH)
|
0.8 |
$24M |
|
159k |
152.65 |
Steris Shares
(STE)
|
0.8 |
$24M |
|
127k |
190.48 |
Dentsply Sirona Common
(XRAY)
|
0.8 |
$22M |
|
351k |
63.81 |
Exact Sciences Corp. Common
(EXAS)
|
0.8 |
$22M |
|
167k |
131.78 |
Alnylam Pharmaceuticals Common
(ALNY)
|
0.8 |
$22M |
|
155k |
141.19 |
Neurocrine Biosciences Common
(NBIX)
|
0.7 |
$21M |
|
213k |
97.25 |
Syneos Health Class A
|
0.7 |
$21M |
|
273k |
75.85 |
Edwards Lifesciences Corp. Common
(EW)
|
0.7 |
$20M |
|
239k |
83.64 |
Novavax Common
(NVAX)
|
0.7 |
$19M |
|
105k |
181.31 |
Allakos Common
(ALLK)
|
0.6 |
$19M |
|
164k |
114.78 |
CRISPR Therapeutics Namen AKT
(CRSP)
|
0.6 |
$18M |
|
151k |
121.85 |
Argenx SE Sponsored ADR
(ARGX)
|
0.6 |
$18M |
|
64k |
275.39 |
AstraZeneca Sponsored ADR
(AZN)
|
0.6 |
$17M |
|
344k |
49.72 |
IDEXX Laboratories Common
(IDXX)
|
0.6 |
$17M |
|
35k |
489.31 |
Alexion Pharmaceuticals Common
|
0.6 |
$17M |
|
111k |
152.91 |
CVS Health Corp. Common
(CVS)
|
0.6 |
$17M |
|
220k |
75.23 |
Iovance Biotherapeutics Common
(IOVA)
|
0.6 |
$17M |
|
521k |
31.66 |
PRA Health Sciences Common
|
0.5 |
$16M |
|
104k |
153.33 |
Intuitive Surgical Common
(ISRG)
|
0.5 |
$16M |
|
21k |
738.92 |
Humana Common
(HUM)
|
0.5 |
$16M |
|
37k |
419.24 |
Ascendis Pharma A/S Sponsored ADR
(ASND)
|
0.5 |
$15M |
|
118k |
128.88 |
Welltower Common
(WELL)
|
0.5 |
$15M |
|
203k |
71.63 |
Mirati Therapeutics Common
|
0.5 |
$14M |
|
84k |
171.30 |
BeiGene Sponsored ADR
(BGNE)
|
0.5 |
$14M |
|
40k |
348.09 |
Deciphera Pharmaceuticals Common
|
0.5 |
$14M |
|
308k |
44.84 |
Arena Pharmaceuticals Common
|
0.5 |
$14M |
|
196k |
69.39 |
Adaptive Biotechnologies Corp. Common
(ADPT)
|
0.5 |
$14M |
|
338k |
40.26 |
IQVIA Holdings Common
(IQV)
|
0.5 |
$14M |
|
70k |
193.14 |
Sutro Biopharma Common
(STRO)
|
0.4 |
$13M |
|
574k |
22.76 |
Charles River Laboratories International Common
(CRL)
|
0.4 |
$13M |
|
43k |
289.83 |
Fate Therapeutics Common
(FATE)
|
0.4 |
$12M |
|
150k |
82.45 |
Blueprint Medicines Corp. Common
(BPMC)
|
0.4 |
$12M |
|
123k |
97.23 |
Novartis Sponsored ADR
(NVS)
|
0.4 |
$12M |
|
136k |
85.48 |
Mettler-Toledo International Common
(MTD)
|
0.4 |
$11M |
|
9.8k |
1155.71 |
Turning Point Therapeutics Common
|
0.4 |
$11M |
|
119k |
94.59 |
Omega Healthcare Investors Common
(OHI)
|
0.4 |
$11M |
|
306k |
36.63 |
Ventas Common
(VTR)
|
0.4 |
$11M |
|
208k |
53.34 |
Ultragenyx Pharmaceutical Common
(RARE)
|
0.4 |
$11M |
|
98k |
113.86 |
Jazz Pharmaceuticals Shares
(JAZZ)
|
0.4 |
$11M |
|
68k |
164.37 |
United Therapeutics Corp. Class B
(UTHR)
|
0.4 |
$11M |
|
64k |
167.27 |
Becton, Dickinson and Common
(BDX)
|
0.4 |
$11M |
|
43k |
243.15 |
Karuna Therapeutics Common
|
0.4 |
$10M |
|
85k |
120.23 |
Owens & Minor Common
(OMI)
|
0.3 |
$10M |
|
266k |
37.59 |
Ionis Pharmaceuticals Common
(IONS)
|
0.3 |
$9.7M |
|
216k |
44.96 |
BioMarin Pharmaceutical Common
(BMRN)
|
0.3 |
$9.7M |
|
128k |
75.51 |
Sarepta Therapeutics Common
(SRPT)
|
0.3 |
$9.6M |
|
129k |
74.53 |
Universal Health Services Class B
(UHS)
|
0.3 |
$9.5M |
|
71k |
133.39 |
G1 Therapeutics Common
|
0.3 |
$9.4M |
|
392k |
24.06 |
Theravance Biopharma Common
(TBPH)
|
0.3 |
$9.3M |
|
456k |
20.41 |
Molina Healthcare Common
(MOH)
|
0.3 |
$9.3M |
|
40k |
233.75 |
Galera Therapeutics Common
(GRTX)
|
0.3 |
$9.2M |
|
1.0M |
8.82 |
Zoetis Class A
(ZTS)
|
0.3 |
$8.9M |
|
57k |
157.48 |
Sabra Health Care REIT Common
(SBRA)
|
0.3 |
$8.9M |
|
511k |
17.36 |
Arrowhead Pharmaceuticals Common
(ARWR)
|
0.3 |
$8.8M |
|
133k |
66.31 |
Medical Properties Trust Common
(MPW)
|
0.3 |
$8.8M |
|
412k |
21.28 |
Physicians Realty Trust Common
|
0.3 |
$8.8M |
|
496k |
17.67 |
Incyte Corp. Common
(INCY)
|
0.3 |
$8.8M |
|
108k |
81.27 |
Denali Therapeutics Common
(DNLI)
|
0.3 |
$8.6M |
|
150k |
57.10 |
ACADIA Pharmaceuticals Common
(ACAD)
|
0.3 |
$8.6M |
|
332k |
25.80 |
Sage Therapeutics Common
(SAGE)
|
0.3 |
$8.5M |
|
114k |
74.85 |
Catalent Common
(CTLT)
|
0.3 |
$8.4M |
|
80k |
105.30 |
I-Mab Sponsored ADS
(IMAB)
|
0.3 |
$8.1M |
|
167k |
48.47 |
Intra-Cellular Therapies Common
(ITCI)
|
0.3 |
$7.9M |
|
233k |
33.93 |
Kura Oncology Common
(KURA)
|
0.3 |
$7.7M |
|
274k |
28.27 |
Teva Pharmaceutical Industries Sponsored ADR
(TEVA)
|
0.3 |
$7.6M |
|
661k |
11.54 |
LTC Properties Common
(LTC)
|
0.3 |
$7.6M |
|
182k |
41.72 |
BioNTech SE Sponsored ADS
(BNTX)
|
0.3 |
$7.5M |
|
69k |
109.19 |
ChemoCentryx Common
|
0.3 |
$7.4M |
|
144k |
51.24 |
Boston Scientific Corp. Common
(BSX)
|
0.2 |
$7.2M |
|
186k |
38.65 |
Replimune Group Common
(REPL)
|
0.2 |
$6.7M |
|
219k |
30.51 |
Agilent Technologies Common
(A)
|
0.2 |
$6.7M |
|
53k |
127.14 |
Apellis Pharmaceuticals Common
(APLS)
|
0.2 |
$6.5M |
|
153k |
42.91 |
Verona Pharma Sponsored ADR
(VRNA)
|
0.2 |
$6.3M |
|
752k |
8.36 |
Amicus Therapeutics Common
(FOLD)
|
0.2 |
$6.1M |
|
622k |
9.88 |
Y-mAbs Therapeutics Common
(YMAB)
|
0.2 |
$6.0M |
|
198k |
30.24 |
Arvinas Common
(ARVN)
|
0.2 |
$5.7M |
|
86k |
66.10 |
Trillium Therapeutics Common
|
0.2 |
$5.7M |
|
529k |
10.74 |
Morphic Holding Common
(MORF)
|
0.2 |
$5.7M |
|
90k |
63.28 |
Atreca Class A Common
(BCEL)
|
0.2 |
$5.4M |
|
352k |
15.33 |
Teladoc Health Common
(TDOC)
|
0.2 |
$5.4M |
|
30k |
181.74 |
Align Technology Common
(ALGN)
|
0.2 |
$5.4M |
|
9.9k |
541.56 |
Travere Therapeutics Common
(TVTX)
|
0.2 |
$5.3M |
|
213k |
24.97 |
TCR2 Therapeutics Common
|
0.2 |
$5.2M |
|
236k |
22.08 |
Aurinia Pharmaceuticals Common
(AUPH)
|
0.2 |
$5.2M |
|
398k |
12.98 |
Amedisys Common
(AMED)
|
0.2 |
$5.1M |
|
19k |
264.81 |
Zai Lab Adr
(ZLAB)
|
0.2 |
$5.0M |
|
38k |
133.44 |
Healthpeak Properties Common
(DOC)
|
0.2 |
$4.8M |
|
150k |
31.74 |
PerkinElmer Common
(RVTY)
|
0.2 |
$4.8M |
|
37k |
128.30 |
Cogent Biosciences Common
(COGT)
|
0.2 |
$4.7M |
|
538k |
8.78 |
Icon Shares
(ICLR)
|
0.2 |
$4.6M |
|
24k |
196.38 |
BridgeBio Pharma Common
(BBIO)
|
0.2 |
$4.6M |
|
75k |
61.59 |
Personalis Common
(PSNL)
|
0.2 |
$4.4M |
|
180k |
24.61 |
Centene Corp. Common
(CNC)
|
0.1 |
$4.3M |
|
67k |
63.92 |
Intellia Therapeutics Common
(NTLA)
|
0.1 |
$4.3M |
|
53k |
80.26 |
uniQure Shares
(QURE)
|
0.1 |
$4.2M |
|
125k |
33.69 |
Forma Therapeutics Holdings Shares
|
0.1 |
$4.2M |
|
150k |
28.02 |
Vir Biotechnology Common
(VIR)
|
0.1 |
$4.2M |
|
81k |
51.27 |
Sanofi Sponsored ADR
(SNY)
|
0.1 |
$4.0M |
|
82k |
49.46 |
Ardelyx Common
(ARDX)
|
0.1 |
$4.0M |
|
608k |
6.62 |
Endo International Shares
|
0.1 |
$3.9M |
|
532k |
7.41 |
Addus HomeCare Corp. Common
(ADUS)
|
0.1 |
$3.9M |
|
38k |
104.60 |
Jounce Therapeutics Common
|
0.1 |
$3.9M |
|
382k |
10.27 |
Takeda Pharmaceutical Sponsored ADS
(TAK)
|
0.1 |
$3.8M |
|
210k |
18.26 |
Reata Pharmaceuticals Class A
|
0.1 |
$3.8M |
|
38k |
99.69 |
Arcutis Biotherapeutics Common
(ARQT)
|
0.1 |
$3.8M |
|
132k |
28.93 |
Smith & Nephew Shares
(SNN)
|
0.1 |
$3.8M |
|
100k |
37.90 |
Nektar Therapeutics Common
(NKTR)
|
0.1 |
$3.6M |
|
180k |
20.00 |
Mereo BioPharma Group Ads
(MREO)
|
0.1 |
$3.4M |
|
997k |
3.37 |
Insmed Common
(INSM)
|
0.1 |
$3.4M |
|
98k |
34.06 |
Novo Nordisk A/S Sponsored ADR
(NVO)
|
0.1 |
$3.3M |
|
48k |
67.43 |
Koninklijke Philips NY Reg Sh
(PHG)
|
0.1 |
$3.2M |
|
57k |
57.04 |
Black Diamond Therapeutics Common
(BDTX)
|
0.1 |
$3.2M |
|
132k |
24.26 |
Alkermes Shares
(ALKS)
|
0.1 |
$3.2M |
|
170k |
18.68 |
Healthcare Realty Trust Common
|
0.1 |
$3.2M |
|
104k |
30.32 |
Tenet Healthcare Corp. Common
(THC)
|
0.1 |
$3.1M |
|
60k |
51.99 |
Medpace Holdings Common
(MEDP)
|
0.1 |
$3.1M |
|
19k |
164.06 |
R1 RCM Common
|
0.1 |
$3.0M |
|
124k |
24.68 |
Xenon Pharmaceuticals Common
(XENE)
|
0.1 |
$3.0M |
|
166k |
17.90 |
Bio-Techne Corp. Common
(TECH)
|
0.1 |
$2.9M |
|
7.6k |
381.97 |
Pieris Pharmaceuticals Common
|
0.1 |
$2.6M |
|
1.0M |
2.57 |
Helix Acquisition Corp. Class A Common
|
0.1 |
$2.6M |
|
250k |
10.24 |
Molecular Templates Common
|
0.1 |
$2.5M |
|
199k |
12.62 |
Praxis Precision Medicines Common
|
0.1 |
$2.5M |
|
75k |
32.76 |
Scholar Rock Holding Corp. Common
(SRRK)
|
0.1 |
$2.4M |
|
48k |
50.66 |
Hologic Common
(HOLX)
|
0.1 |
$2.4M |
|
33k |
74.38 |
Genmab A/S Sponsored ADS
(GMAB)
|
0.1 |
$2.4M |
|
73k |
32.83 |
Global Medical REIT Common
(GMRE)
|
0.1 |
$2.3M |
|
175k |
13.11 |
Affimed Common
|
0.1 |
$2.3M |
|
288k |
7.91 |
Heron Therapeutics Common
(HRTX)
|
0.1 |
$2.1M |
|
131k |
16.21 |
Perrigo Shares
(PRGO)
|
0.1 |
$2.1M |
|
51k |
40.47 |
Healthcare Trust of America Common
|
0.1 |
$1.9M |
|
71k |
27.58 |
MorphoSys Sponsored ADS
(MOR)
|
0.1 |
$1.8M |
|
82k |
21.80 |
Intercept Pharmaceuticals Common
|
0.1 |
$1.8M |
|
77k |
23.08 |
Dicerna Pharmaceuticals Common
|
0.1 |
$1.7M |
|
68k |
25.58 |
Zogenix Common
|
0.1 |
$1.7M |
|
89k |
19.52 |
Diversified Healthcare Trust Common
(DHC)
|
0.1 |
$1.7M |
|
358k |
4.78 |
New Senior Investment Group Common
|
0.1 |
$1.6M |
|
256k |
6.23 |
Community Health Systems Common
(CYH)
|
0.1 |
$1.6M |
|
118k |
13.52 |
Madrigal Pharmaceuticals Common
(MDGL)
|
0.1 |
$1.6M |
|
13k |
116.94 |
Ovid Therapeutics Sponsored ADR
(OVID)
|
0.1 |
$1.5M |
|
373k |
4.02 |
KalVista Pharmaceuticals Common
(KALV)
|
0.0 |
$1.3M |
|
50k |
25.70 |
1Life Healthcare Common
|
0.0 |
$1.2M |
|
31k |
39.08 |
Health Care Select Sector SPDR Fund SBI Healthcare
(XLV)
|
0.0 |
$1.2M |
|
10k |
116.76 |
Assertio Holdings Common
|
0.0 |
$1.1M |
|
1.6M |
0.68 |
Gamida Cell Shares
|
0.0 |
$956k |
|
118k |
8.09 |
Nkarta Common
(NKTX)
|
0.0 |
$954k |
|
29k |
32.91 |
VYNE Therapeutics Common
|
0.0 |
$927k |
|
135k |
6.85 |
Teleflex Common
(TFX)
|
0.0 |
$914k |
|
2.2k |
415.45 |
Grifols Sponsored ADR
(GRFS)
|
0.0 |
$819k |
|
47k |
17.29 |
Corbus Pharmaceuticals Holdings Common
|
0.0 |
$815k |
|
414k |
1.97 |
Universal Health Realty Income Trust Shares
(UHT)
|
0.0 |
$763k |
|
11k |
67.77 |
Regenxbio Common
(RGNX)
|
0.0 |
$740k |
|
22k |
34.10 |
National Health Investors Common
(NHI)
|
0.0 |
$726k |
|
10k |
72.33 |
Community Healthcare Trust Common
(CHCT)
|
0.0 |
$687k |
|
15k |
46.11 |
Precision BioSciences Common
|
0.0 |
$652k |
|
63k |
10.35 |
Editas Medicine Common
(EDIT)
|
0.0 |
$638k |
|
15k |
42.00 |
Clearside Biomedical Common
(CLSD)
|
0.0 |
$408k |
|
165k |
2.47 |
CymaBay Therapeutics Common
|
0.0 |
$400k |
|
88k |
4.54 |
Spectrum Pharmaceuticals Common
|
0.0 |
$374k |
|
115k |
3.26 |
Cellectis Sponsored ADR
(CLLS)
|
0.0 |
$242k |
|
12k |
20.24 |
Five Star Senior Living Common
|
0.0 |
$148k |
|
24k |
6.11 |
Celldex Therapeutics Common
(CLDX)
|
0.0 |
$145k |
|
7.1k |
20.56 |
ARCA biopharma Common
(ABIO)
|
0.0 |
$118k |
|
33k |
3.64 |
Bellicum Pharmaceuticals Common
|
0.0 |
$23k |
|
6.0k |
3.83 |
Tetraphase Pharmaceuticals Common
|
0.0 |
$9.0k |
|
43k |
0.21 |